PhRMA Foundation funding opportunities to support research in Drug Delivery and Drug Discovery. Funding of up to $100,000 is available, with categories including predoctoral fellowships, postdoctoral fellowships and research starter grants.
PhRMA url   http://www.phrmafoundation.org/awards/
Deadline for Letters of Intent is May 20, 2021. 

Drug Delivery strongly emphasizes the quantitative understanding and use of the principles underlying drug transport, route of administration, formulation composition, technology development and manufacturing/engineering aspects intended to improve drug product safety and efficacy, including patient compliance. Drug delivery research falls into four broad categories—drugs, delivery vehicles and formulations, routes of delivery, and targeting strategies. Today’s “drugs” include small molecules, peptides, proteins, antibodies, vaccines, oligonucleotides (gene modification), modified live cells (stem cells, CAR-T cells), bacteria (microbiome related) and viruses as delivery vectors. Developing vehicles and novel technologies is important for delivering increasingly complex drugs by alternate routes of administration. Of equal importance is the quantitative impact of drug molecular properties and formulation composition on the engineering factors and subsequent manufacturing processes.

Drug Discovery is the process through which potential new medicines are identified. It involves integration of a range of scientific disciplines, including innovative and unique biology, chemistry and pharmacology. Modern drug discovery has extended beyond traditional small molecules to embrace a variety of novel therapeutic approaches, including peptides, oligonucleotides, antibodies, proteins, stem cells and CAR-T cells. The evolving process of drug discovery should include innovative culture-based and animal-based efforts that embrace new cutting-edge technology, including target-specific structural and computational drug-based design and the use of genomics.